ClinicalTrials.gov
public full text
Public Domain
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
Hydroxyurea was found to be a good treatment in adult patients with sickle cell anemia with significant decrease in the frequency of vaso-occlusive crises and other crises related to SCA. Several studies were published with relative short term follow up in pediatric and young adult age. The purpose of this study is to assess the long term follow up in a group of patients that initiated Hydroxyurea treatment in childhood.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia#855703
- Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)#918538
- Effect of Motor Imagery Training on Ataxic Children After Medulloblastoma Resection#835081
- Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease.#1164994
- 38 U.S.C. § 1822 — Benefits for children of certain Thailand service veterans born with spina bifida#587186
Record · ID 1429460
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive